Study aims to identify Parkinson's biomarkers

07/28/2013 | American City Business Journals

Researchers at the Emory University School of Medicine are planning a study to analyze the possibility of diagnosing asymptomatic Parkinson's disease. The study will examine biomarkers indicative of disease progression, with researchers performing SPECT imaging, MRI and other tests to trace the progression to symptomatic disease. The research is part of the Parkinson's Progression Markers Initiative, created by The Michael J. Fox Foundation for Parkinson's Research.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC